James Firmage

Patient Advocacy & Community Partnerships at 4D Molecular Therapeutics LLC - Oakland, CA, US

James Firmage's Colleagues at 4D Molecular Therapeutics LLC
Teri Roy

Associate Director, Clinical Regulatory Affairs

Contact Teri Roy

Ziyao Jiang

Senior Manufacturing Associate

Contact Ziyao Jiang

Anthony Baldor

Vice President, Corporate Strategy and Development

Contact Anthony Baldor

David Asarnow

Director, Quality & Compliance

Contact David Asarnow

Cecilia Yu

Associate Director Project Management

Contact Cecilia Yu

Paula Lea

Associate Clinical Trial Manager

Contact Paula Lea

View All James Firmage's Colleagues
James Firmage's Contact Details
HQ
510-505-2680
Location
Mill Valley,California,94941,United States
Company
4D Molecular Therapeutics LLC
James Firmage's Company Details
4D Molecular Therapeutics LLC logo, 4D Molecular Therapeutics LLC contact details

4D Molecular Therapeutics LLC

Oakland, CA, US • 100 - 249 Employees
BioTech/Drugs

We are 4DMT! Our mission is to boldly innovate to unlock the full potential of gene therapy for countless patients. 4DMT is a leader in next-generation AAV gene therapy discovery through its proprietary therapeutic vector evolution platform that empowers us to invent optimized and proprietary AAV vectors, each specifically tailored for the treatment of a rare disease with a high unmet medical need. We strive to become the most impactful company in the gene therapy industry.We are pioneering the development of precision gene therapies based on our proprietary AAV vectors. Our transformative discovery platform, Therapeutic Vector Evolution, enables our "disease first" approach to product discovery, design and development. We use our platform to discover custom and proprietary AAVs designed for specific tissues and diseases, which we believe will allow us to overcome known limitations of conventional AAV vectors and potentially address a broad range of both rare and large market diseases. Based on our Target Vector Profile for a disease, we select customized capsids in non-human primates from an estimated over one billion vector capsid sequences in our 37 proprietary and diverse AAV vector libraries as of August 1, 2019. We are developing a diverse pipeline in a broad range of therapeutic areas of wholly owned and partnered programs.We seek the best in the industry who identify with our mission and innovative results-driven approach. Our 4 Guiding Principles drive our actions, and they are: Dare to Cure (create big dreams for patients, innovate and take calculated risks to achieve them); Break Boundaries (questioning and moving beyond the status quo); Beyond Yourself (we are patient and team focused); and Prepare & Executive Relentlessly (be proactive and start with the end in mind).

Gene Therapy Adeno-Associated Virus B2B Biotech SaaS Commercial Physical Research Biotechnology Biotech Pharmaceuticals
Details about 4D Molecular Therapeutics LLC
Frequently Asked Questions about James Firmage
James Firmage currently works for 4D Molecular Therapeutics.
James Firmage's role at 4D Molecular Therapeutics is Patient Advocacy & Community Partnerships.
James Firmage's email address is ***@4dmoleculartherapeutics.com. To view James Firmage's full email address, please signup to ConnectPlex.
James Firmage works in the Research industry.
James Firmage's colleagues at 4D Molecular Therapeutics LLC are Teri Roy, Ziyao Jiang, Albena Kantardzhieva, Anthony Baldor, David Asarnow, Cecilia Yu, Paula Lea and others.
James Firmage's phone number is 510-505-2680
See more information about James Firmage